Soft signs, neuroleptic side effects, and schizophrenia

Psychiatric Annals

Volumn 33, Issue 3, 2003, Pages 214-220

  Schröder, Johannes ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENPERIDOL; BIPERIDEN; CLOZAPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; IOBENZAMIC ACID; NEUROLEPTIC AGENT;

AKATHISIA; BINDING AFFINITY; BRAIN REGION; CLINICAL FEATURE; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SCREENING; EXTRAPYRAMIDAL SYMPTOM; FOLLOW UP; HUMAN; MENTAL DISEASE; MENTAL PATIENT; METHODOLOGY; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; PARKINSONISM; PATHOGENESIS; PATHOPHYSIOLOGY; PROGNOSIS; RATING SCALE; RECEPTOR UPREGULATION; REVIEW; SCHIZOPHRENIA; SENSORY DYSFUNCTION; TARDIVE DYSKINESIA;

EID: 18844467359     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20030301-10     Document Type: Review

References (35)

1. Heinrichs DW, Buchanan RW. Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry. 1988;145:11-18.
2. Jahn T. Diskrete Motorische Störungen bei Schizophrenie. Weinheim, Germany: Beltz /Psychologie Verlags Union; 1999.
3. Boks MPM, Russo S, Knegtering R, van den Bosch RJ. The specificity of neurological signs in schizophrenia: a review. Schizophr Res. 2000;43:109-116.
4. Quitkin F, Rifkin A, Klein DF. Neurologic soft signs in schizophrenia and character disorders. Organicity in schizophrenia with premorbid asociality and emotionally unstable character disorders. Arch Gen Psychiatry. 1976;33:845-853.
5. Torrey EF. Neurological abnormalities in schizophrenic patients. Biol Psychiatry. 1980;15:381-388.
6. Woods BT, Kinney DK, Yurgelun-Todd D. Neurologic abnormalities in schizophrenic patients and their families, I: comparison of schizophrenic, bipolar, and substance abuse patients and normal controls. Arch Gen Psychiatry. 1986;43:657-663.
7. Johnstone EC, MacMillan JF, Frith CD, Benn DK, Crow TJ. Further investigation of the predictors of outcome following first schizophrenic episodes. Br J Psychiatry. 1990;157: 182-189.
8. Chen YL, Chen YH, Mak FL. Soft neurological signs in schizophrenic patients and their nonpsychotic siblings. J Ner Ment Dis. 2000;188:849-889.
9. Niethammer R, Weisbrod M, Schiesser S, et al. Genetic influence on laterality in schizophrenia? A twin study on neurological soft signs. Am J Psychiatry. 2000;157:272-274.
10. Walker EF. Neurodevelopmental precursors of schizophrenia. In: David AS, Cutting JC, eds. The Neuropsychology of Schizophrenia. Hillsdale, NJ: Erlbaum; 1994:119-129.
11. Tucker GJ, Silberfarb PM. Neurologic dysfunction in schizophrenia: significance for diagnostic practice. In: Akiskal HS, Webb WL, eds. Psychiatric Diagnosis: Exploration of Biological Predictors. New York, NY: Sp Medical and Scientific Books. 1978:453-462.
12. Schröder J, Niethammer R, Geider FJ, et al. Neurological soft signs in schizophrenia. Schizophr Res. 1992;6:25-30.
13. Schröder J, Tittel A, Stockert A, Karr M. Memory deficits in subsyndromes of chronic schizophrenia. Schizophr Res. 1996;21:19-26.
14. Schröder J, Silvestri S, Bubeck B, et al. D2 dopamine receptor upregulation, treatment response, neurological soft signs, and extra-pyramidal side effects in schizophrenia: a follow-up study with 123I-IBZM SPECT in the drug-naive state and after neuroleptic treatment. Biol Psychiatry. 1998;42:660-665.
15. Jahn T, Cohen R, Hubmann W, et al. The Brief Motor Scale (BMS) for the assessment of motor soft signs in schizophrenic psychoses and other psychiatric disorders. Psychiatry Res. In press.
16. Manschreck TC, Maher BA, Rucklos ME, Vereen DR. Disturbed voluntary motor activity in schizophrenic disorder. Psychol Med. 1982;12:73-84.
17. Buchanan RW, Kirkpatrick B, Heinrichs DW, Carpenter WT. Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry. 1990;147:290-294.
18. Mohr F, Hubmann W, Cohen R, et al. Neurological soft signs in schizophrenia: assessment and correlates. Eur Arch Psychiatry Clin Neurosci. 1996;246:240-248.
19. Youssef HA, Waddington JL. Primitive (developmental) reflexes and diffuse cerebral dysfunction in schizophrenia and bipolar affective disorder: overrepresentation in patients with tardive dyskinesia. Biol Psychiatry. 1988;23:791-796.
20. King DJ, Wilson A, Cooper SJ, Waddington JL. The clinical correlates of neurological soft signs in chronic schizophrenia. Br J Psychiatry. 1991;158:770-775.
21. Buchanan RW, Koeppl P, Breier A. Stability of neurological signs with clozapine treatment. Biol Psychiatry. 1994;36:198-200.
22. Gupta S, Andreasen NC, Arndt S, et al. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. Am J Psychiatry. 1995;152:191-196.
23. Sanders RD, Keshavan MS, Schooler NR. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. Am J Psychiatry. 1994;151:1231-1233.
24. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962;10:799-812.
25. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl. 1970;212:11-19.
26. Schröder J, Richter P, Geider FJ, et al. Diskrete motorische und sensorische Störungen (neurologische soft signs) im Akutverlauf endogener Psychosen. Zeitschrift für Klinische Psychologie Psychopathologie und Psychotherapie. 1993;41:190-206.
27. Jahn T, Hubmann W, Karr M, et al. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses. Psychiatry Res. In press.
28. Sachdev P. The epidemiology of drug-induced akathisia, I: Acute akathisia. Schizophr Bull. 1995;21:431-449.
29. Karr M, Schröder J, Tittel A. Neurologische soft signs und neuropsychologische Störungen bei schizophrenen Psychosen. Nervenheilkunde. 1996;15:326-331.
30. Rubin P, Vorstrup S, Hemmingsen R, et al. Neurological abnormalities in patients with schizophrenia or schizophreniform disorder at first admission to hospital: correlations with computerized tomography and regional cerebral blood flow findings. Acta Psychiatr Scand. 1994;90:385-390.
31. Günther W, Brodie JD, Bartlett EL, et al. Diminished cerebral metabolic response to motor stimulation in schizophrenia: a PET study. Eur Arch Psychiatry Clin Neurosci. 1994;244:115-125.
32. Schröder J, Wenz F, Baudendistel K, Schad LR, Knopp MV. Sensorimotor cortex and supplementary motor area activation changes in schizophrenia: a study with functional magnetic resonance imaging. Br J Psychiatry. 1994;167:197-201.
33. Schröder J, Essig M, Baudendistel K, et al. Motor dysfunction and sensorimotor cortex activation changes in schizophrenia: a study with functional magnetic resonance imaging. NeuroImage. 1999;9:81-87.
34. Chatterjee A, Chakos M, Koreen A, et al. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry. 1995;152:1724-1729.
35. McCreadie R, Thara R, Kamath S, et al. Abnormal movements in never medicated Indian patients with schizophrenia. Br J Psychiatry. 1996;168:221-226.